December 1, 2022Open Access
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov Identifier: NCT02614794.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
N
Nancy U. Lin
Cardio-Oncology
R
Rashmi K. Murthy
The University of Texas MD Anderson Cancer Center
Vandana G. Abramson
Vanderbilt University
Journals
JAMA Oncology
Actions
Institutions
University of California, Los Angeles
University of Wisconsin–Madison
Dana-Farber Cancer Institute
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...